Observational studyCancer control : journal of the Moffitt Cancer Center
Safety and Outcomes With Combination Therapy With Sarilumab and Baricitinib for Severe COVID-19 Respiratory Infection in Cancer Patients.
Ana Paula Velez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.